Home > Quotes > PHMD > Guru Analysis > Peter Lynch

Peter Lynch Guru Analysis for PhotoMedex, Inc.

Get PHMD Alerts
*Delayed - data as of Dec. 26, 2014 15:57 ET  -  Find a broker to begin trading PHMD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    PHMD After Hours
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Assessments & Analysis Based on December 24, 2014 close price: $1.46

  for the P/E/Growth Investor based on the criteria of Peter Lynch. Return to PHMD Guru Analysis

All Star Guru Scorecard

Source Go Chart %
Peter Lynch 0%
Benjamin Graham 43%
Validea 0%
Motley Fool 35%
David Dreman 33%
Martin Zweig 23%
Kenneth Fisher 50%
James P. O'Shaughnessy 25%

Detailed Analysis

Guru Score: 0%

Determine the Classification:

According to this methodology, PHMD is a "Slow Grower", based on its single digit earnings growth of 7.68%, Based on the average of the 3 and 4 year historical EPS growth rates.


PHMD would fall into the "Dividend Payers" category according to this methodology. The first requirement of a Slow Grower is that its sales exceed one billion. PHMD's sales are $219 million. It fails the test.

Inventory To Sales: [PASS]

When inventories increase faster than sales, it is a red flag. However an increase of up to 5% is considered bearable if all other ratios appear attractive. Inventory to sales for PHMD was 10.18% last year, while for this year it is 12.26%. Since inventory has been rising, this methodology would not look favorably at the stock but would not completely eliminate it from consideration as the inventory increase (2.08%) is below 5%.


This methodology also maintains that the Yield of a "Slow Grower" should be high, which includes being higher than the S&P average (currently 2.15%). The yield for PHMD is not available, which means this criterion cannot be analyzed.


Unfortunately PHMD's P/E/G ratio is not available at the current time which means this criterion cannot be analyzed. This criteria is the most important one in the methodology and a failure of it will automatically result in a 0% score for the overall analysis.

Total Debt/Equity Ratio: [PASS]

This methodology would consider the Debt/Equity ratio for PHMD (57.77%) to be mediocre. If the Debt/Equity ratio is this high, the other ratios and financial statistics for PHMD should be good enough to compensate.

FREE CASH FLOW: The Free Cash Flow/Price ratio, though not a requirement, is considered a bonus if it above 35%. A positive Cash Flow (the higher the better) separates a wonderfully reliable investment from a shaky one. This methodology prefers not to invest in companies that rely heavily on capital spending. This ratio for PHMD (65.75%) is high enough to add to the attractiveness of the stock.

NET CASH POSITION: Another bonus for a company is having a Net Cash/Price ratio above 30%. Lynch defines net cash as cash and marketable securities minus long term debt. According to this methodology, a high value for this ratio dramatically cuts down on the risk of the security. The Net Cash/Price ratio for PHMD (214.5%) is considered very favorable.

The names of individual investment advisors (i.e., the 'gurus') appearing ON THIS WEBSITE are for identification purposes ONLY. The names are used to identify the methodology as derived from the guru's published sources. The names of the individual gurus are not intended to suggest or imply any affiliation with or endorsement of, or even any agreement with the information displayed on this website personally by such gurus, or any knowledge or approval by such persons of the content on this website. All trademarks, service marks and trade names appearing on this website are the property of their respective owners, and are likewise used for identification purposes only.

The NASDAQ Stock Market, Inc. ("NASDAQ"), its affiliates, third party information providers, or any of these entities' officers, employees, directors, or agents have not: (1) passed on the merit of the information provided on this website or on any of these securities; or (2) endorsed or sponsored any of these securities. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED. The information contained on this website is provided for informational purposes only. See Full Disclaimer Below
See Full Disclaimer
The Validea Market Legends ETF (VALX)